Acute 0 5 0 5 B-cancer
lymphocytic 6 17 6 17 I-cancer
leukemia 18 26 18 26 I-cancer
or 27 29 27 29 O
acute 30 35 30 35 B-cancer
myelogenous 36 47 36 47 I-cancer
leukemia 48 56 48 56 I-cancer
who 57 60 57 60 O
are 61 64 61 64 O
not 65 68 65 68 O
in 69 71 69 71 O
first 72 77 72 77 O
remission 78 87 78 87 O
or 88 90 88 90 O
second 91 97 91 97 O
remission 98 107 98 107 O
i.e. 108 112 108 112 O
after 113 118 113 118 O
failing 119 126 119 126 O
induction 127 136 127 136 B-treatment
therapy 137 144 137 144 I-treatment
, 144 145 144 145 O
or 146 148 146 148 O
in 149 151 149 151 O
relapse 152 159 152 159 O
or 160 162 160 162 O
beyond 163 169 163 169 O
second 170 176 170 176 O
remission 177 186 177 186 O
; 186 187 186 187 O
( 188 189 188 189 O
prior 189 194 189 194 B-treatment
therapy 195 202 195 202 I-treatment
with 203 207 203 207 O
VP-16 208 213 208 213 B-treatment
and 214 217 214 217 O
Cytoxan 218 225 218 225 B-treatment
is 226 228 226 228 O
allowed 229 236 229 236 O
) 236 237 236 237 O

Agreement 0 9 238 247 O
of 10 12 248 250 O
men 13 16 251 254 B-gender
AND 17 20 255 258 I-gender
women 21 26 259 264 I-gender
- 26 27 264 265 O
of 27 29 265 267 O
- 29 30 267 268 O
child 30 35 268 273 O
- 35 36 273 274 O
bearing 36 43 274 281 O
- 43 44 281 282 O
potential 44 53 282 291 O
to 54 56 292 294 O
use 57 60 295 298 B-chronic_disease
adequate 61 69 299 307 I-chronic_disease
contraception 70 83 308 321 I-chronic_disease
( 84 85 322 323 O
hormonal 85 93 323 331 B-contraception_consent
or 94 96 332 334 O
barrier 97 104 335 342 B-contraception_consent
method 105 111 343 349 I-contraception_consent
of 112 114 350 352 I-contraception_consent
birth 115 120 353 358 I-contraception_consent
control 121 128 359 366 I-contraception_consent
or 129 131 367 369 O
abstinence 132 142 370 380 B-contraception_consent
) 142 143 380 381 O
prior 144 149 382 387 O
to 150 152 388 390 O
study 153 158 391 396 O
entry 159 164 397 402 O
and 165 168 403 406 O
for 169 172 407 410 O
six 173 176 411 414 B-upper_bound
months 177 183 415 421 I-upper_bound
following 184 193 422 431 O
duration 194 202 432 440 O
of 203 205 441 443 O
study 206 211 444 449 O
participation 212 225 450 463 O
; 225 226 463 464 O
should 227 233 465 471 O
a 234 235 472 473 O
woman 236 241 474 479 B-gender
become 242 248 480 486 O
pregnant 249 257 487 495 B-pregnancy
or 258 260 496 498 O
suspect 261 268 499 506 O
that 269 273 507 511 O
she 274 277 512 515 O
is 278 280 516 518 O
pregnant 281 289 519 527 O
while 290 295 528 533 O
participating 296 309 534 547 O
on 310 312 548 550 O
the 313 316 551 554 O
trial 317 322 555 560 O
, 322 323 560 561 O
she 324 327 562 565 O
should 328 334 566 572 O
inform 335 341 573 579 O
her 342 345 580 583 O
treating 346 354 584 592 O
physician 355 364 593 602 O
immediately 365 376 603 614 O

All 0 3 615 618 O
candidates 4 14 619 629 O
for 15 18 630 633 O
this 19 23 634 638 O
study 24 29 639 644 O
must 30 34 645 649 O
have 35 39 650 654 O
a 40 41 655 656 O
human 42 47 657 662 B-treatment
leukocyte 48 57 663 672 I-treatment
antigen 58 65 673 680 I-treatment
( 66 67 681 682 I-treatment
HLA 67 70 682 685 I-treatment
) 70 71 685 686 I-treatment
( 72 73 687 688 O
A 73 74 688 689 O
, 74 75 689 690 O
B 76 77 691 692 O
, 77 78 692 693 O
C 79 80 694 695 O
, 80 81 695 696 O
DR 82 84 697 699 O
) 84 85 699 700 O
identical 86 95 701 710 O
siblings 96 104 711 719 O
who 105 108 720 723 O
is 109 111 724 726 O
willing 112 119 727 734 O
to 120 122 735 737 O
donate 123 129 738 744 O
bone 130 134 745 749 O
marrow 135 141 750 756 O
or 142 144 757 759 O
primed 145 151 760 766 O
blood 152 157 767 772 O
stem 158 162 773 777 O
cells 163 168 778 783 O
or 169 171 784 786 O
a 172 173 787 788 O
10/10 174 179 789 794 O
allele 180 186 795 801 O
matched 187 194 802 809 O
unrelated 195 204 810 819 O
donor 205 210 820 825 O

Chemotherapy 0 12 826 838 B-treatment
given 13 18 839 844 O
within 19 25 845 851 O
14 26 28 852 854 B-upper_bound
days 29 33 855 859 I-upper_bound
of 34 36 860 862 O
planned 37 44 863 870 O
study 45 50 871 876 O
enrollment 51 61 877 887 O
for 62 65 888 891 O
the 66 69 892 895 O
purpose 70 77 896 903 O
of 78 80 904 906 O
controlling 81 92 907 918 O
counts 93 99 919 925 O
is 100 102 926 928 O
permitted 103 112 929 938 O

Echocardiogram 0 14 939 953 B-treatment
( 15 16 954 955 I-treatment
ECHO 16 20 955 959 I-treatment
) 20 21 959 960 I-treatment
or 22 24 961 963 O
multi 25 30 964 969 B-treatment
gated 31 36 970 975 I-treatment
acquisition 37 48 976 987 I-treatment
scan 49 53 988 992 I-treatment
( 54 55 993 994 I-treatment
MUGA 55 59 994 998 I-treatment
): 59 61 998 1000 I-treatment
ejection 62 70 1001 1009 B-clinical_variable
fraction 71 79 1010 1018 I-clinical_variable
of 80 82 1019 1021 O
> 83 84 1022 1023 O
= 84 85 1023 1024 O
50 86 88 1025 1027 B-lower_bound
% 88 89 1027 1028 I-lower_bound

Karnofsky 0 9 1029 1038 B-clinical_variable
performance 10 21 1039 1050 I-clinical_variable
status 22 28 1051 1057 I-clinical_variable
> 29 30 1058 1059 O
= 30 31 1059 1060 O
70 32 34 1061 1063 B-lower_bound
% 34 35 1063 1064 I-lower_bound
= 36 37 1065 1066 O
< 37 38 1066 1067 O
2 39 40 1068 1069 B-upper_bound

Measured 0 8 1070 1078 B-clinical_variable
creatinine 9 19 1079 1089 I-clinical_variable
clearance 20 29 1090 1099 I-clinical_variable
> 30 31 1100 1101 O
= 31 32 1101 1102 O
80 33 35 1103 1105 B-lower_bound
ml 36 38 1106 1108 I-lower_bound
/ 38 39 1108 1109 I-lower_bound
min 39 42 1109 1112 I-lower_bound
per 43 46 1113 1116 O
24 47 49 1117 1119 O
hour 50 54 1120 1124 O
urine 55 60 1125 1130 O
collection 61 71 1131 1141 O
OR 72 74 1142 1144 O
serum 75 80 1145 1150 B-clinical_variable
creatinine 81 91 1151 1161 I-clinical_variable
= 92 93 1162 1163 O
< 93 94 1163 1164 O
1.3 95 98 1165 1168 B-upper_bound
mg 99 101 1169 1171 I-upper_bound
/ 101 102 1171 1172 I-upper_bound
dL 102 104 1172 1174 I-upper_bound

Plans 0 5 1175 1180 O
during 6 12 1181 1187 O
the 13 16 1188 1191 O
trial 17 22 1192 1197 O
to 23 25 1198 1200 O
receive 26 33 1201 1208 O
any 34 37 1209 1212 O
other 38 43 1213 1218 O
( 44 45 1219 1220 O
non 45 48 1220 1223 O
- 48 49 1223 1224 O
trial 49 54 1224 1229 O
) 54 55 1229 1230 O
investigational 56 71 1231 1246 B-treatment
agents 72 78 1247 1253 I-treatment
, 78 79 1253 1254 O
or 80 82 1255 1257 O
concurrent 83 93 1258 1268 O
biological 94 104 1269 1279 O
, 104 105 1279 1280 O
chemotherapy 106 118 1281 1293 B-treatment
, 118 119 1293 1294 O
or 120 122 1295 1297 O
radiation 123 132 1298 1307 B-treatment
therapy 133 140 1308 1315 I-treatment

Prior 0 5 1316 1321 B-treatment
radiation 6 15 1322 1331 I-treatment
therapy 16 23 1332 1339 I-treatment
that 24 28 1340 1344 O
would 29 34 1345 1350 O
exclude 35 42 1351 1358 O
the 43 46 1359 1362 O
use 47 50 1363 1366 O
of 51 53 1367 1369 O
TMLI 54 58 1370 1374 O

Pulmonary 0 9 1375 1384 O
function 10 18 1385 1393 O
tests 19 24 1394 1399 O
: 24 25 1399 1400 O
Forced 26 32 1401 1407 B-clinical_variable
expiratory 33 43 1408 1418 I-clinical_variable
volume 44 50 1419 1425 I-clinical_variable
in 51 53 1426 1428 I-clinical_variable
one 54 57 1429 1432 I-clinical_variable
second 58 64 1433 1439 I-clinical_variable
( 65 66 1440 1441 I-clinical_variable
FEV1 66 70 1441 1445 I-clinical_variable
) 70 71 1445 1446 I-clinical_variable
and 72 75 1447 1450 O
carbon 76 82 1451 1457 B-clinical_variable
monoxide 83 91 1458 1466 I-clinical_variable
diffusion 92 101 1467 1476 I-clinical_variable
capacity 102 110 1477 1485 I-clinical_variable
( 111 112 1486 1487 I-clinical_variable
DLCO 112 116 1487 1491 I-clinical_variable
) 116 117 1491 1492 I-clinical_variable
( 118 119 1493 1494 O
adjusted 119 127 1494 1502 O
for 128 131 1503 1506 O
Hb 132 134 1507 1509 B-clinical_variable
) 134 135 1509 1510 O
> 136 137 1511 1512 O
= 137 138 1512 1513 O
50 139 141 1514 1516 B-lower_bound
% 141 142 1516 1517 I-lower_bound
adjusted 143 151 1518 1526 O
of 152 154 1527 1529 O
predicted 155 164 1530 1539 O
normal 165 171 1540 1546 O
value 172 177 1547 1552 O

Serum 0 5 1553 1558 B-clinical_variable
glutamic 6 14 1559 1567 I-clinical_variable
oxaloacetic 15 26 1568 1579 I-clinical_variable
transaminase 27 39 1580 1592 I-clinical_variable
( 40 41 1593 1594 I-clinical_variable
SGOT 41 45 1594 1598 I-clinical_variable
) 45 46 1598 1599 I-clinical_variable
and 47 50 1600 1603 O
serum 51 56 1604 1609 B-clinical_variable
glutamate 57 66 1610 1619 I-clinical_variable
pyruvate 67 75 1620 1628 I-clinical_variable
transaminase 76 88 1629 1641 I-clinical_variable
( 89 90 1642 1643 I-clinical_variable
SGPT 90 94 1643 1647 I-clinical_variable
) 94 95 1647 1648 I-clinical_variable
= 96 97 1649 1650 O
< 97 98 1650 1651 O
5 99 100 1652 1653 B-upper_bound
x 101 102 1654 1655 I-upper_bound
ULN 103 106 1656 1659 I-upper_bound

The 0 3 1660 1663 O
time 4 8 1664 1668 O
from 9 13 1669 1673 O
the 14 17 1674 1677 O
end 18 21 1678 1681 O
last 22 26 1682 1686 O
induction 27 36 1687 1696 O
, 36 37 1696 1697 O
re 38 40 1698 1700 O
- 40 41 1700 1701 O
induction 41 50 1701 1710 O
, 50 51 1710 1711 O
or 52 54 1712 1714 O
consolidation 55 68 1715 1728 B-clinical_variable
regimen 69 76 1729 1736 I-clinical_variable
should 77 83 1737 1743 O
be 84 86 1744 1746 O
greater 87 94 1747 1754 O
than 95 99 1755 1759 O
or 100 102 1760 1762 O
equal 103 108 1763 1768 O
to 109 111 1769 1771 O
14 112 114 1772 1774 B-lower_bound
days 115 119 1775 1779 I-lower_bound
from 120 124 1780 1784 O
planned 125 132 1785 1792 O
start 133 138 1793 1798 O
of 139 141 1799 1801 O
study 142 147 1802 1807 O
treatment 148 157 1808 1817 B-treatment

Total 0 5 1818 1823 B-clinical_variable
bilirubin 6 15 1824 1833 I-clinical_variable
= 16 17 1834 1835 O
< 17 18 1835 1836 O
1.5 19 22 1837 1840 B-upper_bound
x 23 24 1841 1842 I-upper_bound
upper 25 30 1843 1848 I-upper_bound
limit 31 36 1849 1854 I-upper_bound
of 37 39 1855 1857 I-upper_bound
normal 40 46 1858 1864 I-upper_bound
( 47 48 1865 1866 I-upper_bound
ULN 48 51 1866 1869 I-upper_bound
) 51 52 1869 1870 I-upper_bound
OR 53 55 1871 1873 O
3 56 57 1874 1875 B-upper_bound
x 58 59 1876 1877 I-upper_bound
ULN 60 63 1878 1881 I-upper_bound
for 64 67 1882 1885 O
Gilbert 68 75 1886 1893 B-chronic_disease
's 75 77 1893 1895 I-chronic_disease
disease 78 85 1896 1903 I-chronic_disease

Uncontrolled 0 12 1904 1916 O
illness 13 20 1917 1924 B-chronic_disease
including 21 30 1925 1934 O
ongoing 31 38 1935 1942 O
or 39 41 1943 1945 O
active 42 48 1946 1952 O
infection 49 58 1953 1962 B-chronic_disease

Women 0 5 1963 1968 B-gender
of 6 8 1969 1971 O
child 9 14 1972 1977 O
bearing 15 22 1978 1985 O
potential 23 32 1986 1995 O
only 33 37 1996 2000 O
: 37 38 2000 2001 O
Negative 39 47 2002 2010 O
urine 48 53 2011 2016 O
or 54 56 2017 2019 O
serum 57 62 2020 2025 O
pregnancy 63 72 2026 2035 B-pregnancy
test 73 77 2036 2040 O

the 0 3 2041 2044 O
patient 4 11 2045 2052 O
, 11 12 2052 2053 O
family 13 19 2054 2060 O
member 20 26 2061 2067 O
and 27 30 2068 2071 O
transplant 31 41 2072 2082 B-treatment
staff 42 47 2083 2088 O
physician 48 57 2089 2098 O
( 58 59 2099 2100 O
physician 59 68 2100 2109 O
, 68 69 2109 2110 O
nurse 70 75 2111 2116 O
, 75 76 2116 2117 O
and 77 80 2118 2121 O
social 81 87 2122 2128 O
worker 88 94 2129 2135 O
) 94 95 2135 2136 O
meet 96 100 2137 2141 O
at 101 103 2142 2144 O
least 104 109 2145 2150 O
once 110 114 2151 2155 O
prior 115 120 2156 2161 O
to 121 123 2162 2164 O
starting 124 132 2165 2173 O
the 133 136 2174 2177 O
transplant 137 147 2178 2188 O
procedure 148 157 2189 2198 O

